PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
09-Dec-2019 Galderma Investigational Therapy Nemolizumab Granted FDA Breakthrough Therapy Designation for the Treatment of Patients Suffering from Prurigo Nodularis Galderma
09-Dec-2019 Gelesis Secures Over $84 Million in New Capital to Support Commercialization of PLENITY™ Gelesis
09-Dec-2019 Nouscom – First Patient Dosed in a Phase 1 Trial with NOUS-209, an ‘off-the-shelf’ Neoantigen Cancer Vaccine, in MSI-High Solid Tumors Nouscom
09-Dec-2019 HVIVO (“HVIVO”) to merge with OPEN ORPHAN PLC (“OPEN ORPHAN”) The Boards of Open Orphan and hVIVO
09-Dec-2019 Moberg Pharma meets primary endpoint for MOB-015 in a Phase 3 study for the treatment of onychomycosis Moberg Pharma AB
09-Dec-2019 Eisai Presents New Seizure Freedom and Adherence Data Related to Anti-Epileptic Drug FYCOMPA® at the 2019 American Epilepsy Society Annual Meeting Eisai Inc.
09-Dec-2019 Eisai Presents New Seizure Freedom and Adherence Data Related to Anti-Epileptic Drug FYCOMPA® at the 2019 American Epilepsy Society Annual Meeting Eisai Inc.
09-Dec-2019 Eisai Presents New Seizure Freedom and Adherence Data Related to Anti-Epileptic Drug FYCOMPA® at the 2019 American Epilepsy Society Annual Meeting Eisai Inc.
09-Dec-2019 Publication of First In-Human Data Reveals Safety & Efficacy of Tigilanol Tiglate in Solid Tumours QBiotics Group Ltd
09-Dec-2019 Publication of First In-Human Data Reveals Safety & Efficacy of Tigilanol Tiglate in Solid Tumours QBiotics Group Ltd
09-Dec-2019 CNS Pharmaceuticals to Participate in the 8th Annual ROTH Deer Valley Corporate Access Event CNS Pharmaceuticals, Inc.
09-Dec-2019 Hoth Therapeutics And North Carolina State University Initiate Preclinical Gene Therapy Study For The Treatment Of Asthma Hoth Therapeutics, Inc.
09-Dec-2019 CNS Pharmaceuticals to Participate in the 8th Annual ROTH Deer Valley Corporate Access Event CNS Pharmaceuticals, Inc.
09-Dec-2019 CNS Pharmaceuticals to Participate in the 8th Annual ROTH Deer Valley Corporate Access Event CNS Pharmaceuticals, Inc.
09-Dec-2019 Windtree to Host a Conference Call on December 11, 2019 to Provide Development Programs and Financial Update Windtree Therapeutics, Inc.
09-Dec-2019 Gemini Therapeutics and Avitide Enter Into Exclusive License Agreement Avitide, Inc.
09-Dec-2019 AbbVie and Scripps Research announce collaboration to develop a broad range of new therapeutics AbbVie
09-Dec-2019 CNS Pharmaceuticals to Participate in the 8th Annual ROTH Deer Valley Corporate Access Event CNS Pharmaceuticals, Inc.
09-Dec-2019 Athira Pharma Presents Positive Data for NDX-1017 in Alzheimer's Patients at 2019 Clinical Trials on Alzheimer's Disease (CTAD) Conference Athira Pharma, Inc.
09-Dec-2019 Efficacy, Durability of Response and Safety of Onvansertib Demonstrated in Completed Phase 1b Trial in AML Patients Presented in Oral Session at ASH Trovagene, Inc.